KPIs & Operating Metrics(New)
Biopharma Testing VolumeBreakdown Of AssetsClinical VolumeCost Of RevenueCost Of Revenue By SegmentDeferred RevenueEmployee StatisticsGross Margin %Gross Margin By Segment %Gross ProfitGross Profit By SegmentIncome Before Provision For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProperty And Equipment, NetRevenueRevenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Guardant Health (GH) Revenue: 2017-2025

Historic Revenue for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to $265.2 million.

  • Guardant Health's Revenue rose 38.50% to $265.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $902.6 million, marking a year-over-year increase of 30.38%. This contributed to the annual value of $739.0 million for FY2024, which is 31.04% up from last year.
  • Per Guardant Health's latest filing, its Revenue stood at $265.2 million for Q3 2025, which was up 14.27% from $232.1 million recorded in Q2 2025.
  • Guardant Health's Revenue's 5-year high stood at $265.2 million during Q3 2025, with a 5-year trough of $78.7 million in Q1 2021.
  • In the last 3 years, Guardant Health's Revenue had a median value of $177.2 million in 2024 and averaged $182.2 million.
  • Data for Guardant Health's Revenue shows a peak YoY spiked of 38.84% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Guardant Health's Revenue stood at $108.1 million in 2021, then rose by 17.37% to $126.9 million in 2022, then increased by 22.19% to $155.1 million in 2023, then surged by 30.16% to $201.8 million in 2024, then surged by 38.50% to $265.2 million in 2025.
  • Its Revenue stands at $265.2 million for Q3 2025, versus $232.1 million for Q2 2025 and $203.5 million for Q1 2025.